Yellow Fever Vaccination Elicits Broad Functional CD4 + T Cell Responses That Recognize Structural and Nonstructural Proteins
Open Access
- 1 December 2013
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 87 (23) , 12794-12804
Abstract
Yellow fever virus (YFV) can induce acute, life-threatening disease that is a significant health burden in areas where yellow fever is endemic, but it is preventable through vaccination. The live attenuated 17D YFV strain induces responses characterized by neutralizing antibodies and strong T cell responses. This vaccine provides an excellent model for studying human immunity. While several studies have characterized YFV-specific antibody and CD8 + T cell responses, less is known about YFV-specific CD4 + T cells. Here we characterize the epitope specificity, functional attributes, and dynamics of YFV-specific T cell responses in vaccinated subjects by investigating peripheral blood mononuclear cells by using HLA-DR tetramers. A total of 112 epitopes restricted by seven common HLA-DRB1 alleles were identified. Epitopes were present within all YFV proteins, but the capsid, envelope, NS2a, and NS3 proteins had the highest epitope density. Antibody blocking demonstrated that the majority of YFV-specific T cells were HLA-DR restricted. Therefore, CD4 + T cell responses could be effectively characterized with HLA-DR tetramers. Ex vivo tetramer analysis revealed that YFV-specific T cells persisted at frequencies ranging from 0 to 100 cells per million that are detectable years after vaccination. Longitudinal analysis indicated that YFV-specific CD4 + T cells reached peak frequencies, often exceeding 250 cells per million, approximately 2 weeks after vaccination. As frequencies subsequently declined, YFV-specific cells regained CCR7 expression, indicating a shift from effector to central memory. Cells were typically CXCR3 positive, suggesting Th1 polarization, and produced gamma interferon and other cytokines after reactivation in vitro . Therefore, YFV elicits robust early effector CD4 + T cell responses that contract, forming a detectable memory population.Keywords
This publication has 29 references indexed in Scilit:
- Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type ResponseThe Journal of Immunology, 2013
- The early cellular signatures of protective immunity induced by live viral vaccinationEuropean Journal of Immunology, 2012
- Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adultsVaccine, 2011
- Direct ex vivo analysis of allergen-specific CD4+ T cellsJournal of Allergy and Clinical Immunology, 2010
- The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell ResponseThe Journal of Immunology, 2009
- Human Immune Memory to Yellow Fever and Smallpox VaccinationJournal of Clinical Immunology, 2008
- Detection of T H 1/T H 2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assayCytokine, 2008
- Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?Clinical and Experimental Immunology, 2007
- PERSISTENCE OF NEUTRALIZING ANTIBODY 30-35 YEARS AFTER IMMUNIZATION WITH 17D YELLOW-FEVER VACCINE1981
- THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATIONJournal of Experimental Medicine, 1937